Jonathan Li
@DrJLi
Followers
2K
Following
3K
Statuses
750
Infectious disease physician-scientist working on viral evolution, drug resistance and cure of HIV and COVID-19
Boston, MA
Joined September 2012
What an honor to receive the 2024 @BrighamWomens DOM Research Excellence Award! It’s a reflection of the hard work and dedication of the entire lab. Thank you to all of our @bwh_id @mgh_id colleagues and collaborators worldwide!
8
2
75
@firefoxx66 @Dr_MChoudhary Absolutely! @Dr_MChoudhary created it. FYI the HIV env sequences from the single pt represents the entire proviral diversity that we sequenced in our lab. Feel free to use it wherever you want! Here’s more details about Manish for crediting purposes:
1
0
1
A heartfelt congratulations to my mentor Dan Kuritzkes for his well deserved Transformative Leadership Award from @HIVMA presented @IDWeekmtg!
2
5
62
RT @RMKGandhi: It's not too late....Sign up for the Harvard CFAR's fabulous annual symposium now! Please RT @ragoninstitute @profshanecrott…
0
2
0
@LizHighleyman @ScienceTM We did have a couple of participants with either HIV or organ transplant but very limited numbers. We’re working to expand the cohort further
3
0
2
And of course much of the credit goes to the lead authors @eeeejjjaaaa @Dr_MChoudhary and James Regan!
0
0
5
Emerging Spike mutations were more common in the severely IC participants, including resistance mutations in those treated with monoclonal antibodies 5/
1
1
4
The severe heme onc/transplant (S-HT) group demonstrated the slowest clearance of both viral RNA (median 72 days) and culturable virus (median 40d). The NS and non-IC groups had similar viral kinetics while the severe autoimmune (S-A) group demonstrated an intermediate risk 4/
1
0
4
The IC pts were older and received more antiviral treatment. Both IC and non-IC participants enrolled with a similar duration of symptoms, received a median of 3 vaccinations and were largely infected with the Omicron variant 3/
1
0
4